Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

CTXR - Citius Pharmaceuticals, Inc.... | Finranks

Home

/

CTXR

C

Citius Pharmaceuticals, Inc. (CTXR)

NCM – Real Time Price. Currency in USD

0.71

-0.01 (-0.81%)

Market open: Aug 12, 2026, 12:50 PM EDT

0.71

-0.01 (-1.39%)

Previous after-hours: Aug 11, 2026, 7:47 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-214K

-210K

-194K

-180K

Gross Profit

-214K

-210K

-194K

-180K

Operating expenses (excl. COGS)

-38M

-42M

-37M

-33M

Operating Income

-39M

-42M

-37M

-33M

Non-operating income, total

-158K

3M

5M

251K

Pretax income

-39M

-39M

-32M

-33M

Equity in earnings

0

0

0

0

Taxes

-1M

-576K

-576K

-576K

Non-controlling/minority interest

2M

287K

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-37M

-39M

-33M

-34M

Discontinued operations

0

0

0

0

Net income

-37M

-39M

-33M

-34M

Dilution adjustment

0

0

0

0

Preferred dividends

0

1M

1M

0

Name

2025

2024

2023

2022

Total assets

131M+12.4%

117M+12.6%

104M-9.1%

114M

Total current assets

28M

14M

34M

45M

Total non-current assets

103M

102M

69M

69M

Total liabilities

54M+26.1%

43M+249.4%

12M+15.2%

11M

Total current liabilities

45M

36M

6M

5M

Total non-current liabilities

9M

7M

6M

6M

Total equity

78M

74M

91M

103M

Total liabilities & shareholders' equities

131M

117M

104M

114M

Total debt

2M+589.8%

263K-45.4%

481K-29.0%

678K

Name

2025

2024

2023

2022

Cash from operating activities

-27M

-28M

-29M

-28M

Cash from investing activities

-6M

-5M

0

0

Cash from financing activities

33M

10M

14M

0

Free cash flow

-27M+5.8%

-28M+3.0%

-29M-2.5%

-28M